Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,972 | 58,056 | 60,944 | 39,597 | 44,097 |
| Marketable Securities | 5,282 | 5,080 | 1,430 | 2,434 | 6,183 |
| Receivables | 16,267 | 15,049 | 13,732 | 13,659 | 14,391 |
| Inventories | 15,253 | 15,088 | 17,746 | 18,765 | 19,715 |
| TOTAL | $81,001 | $94,801 | $96,166 | $79,125 | $86,112 |
| Non-Current Assets | |||||
| PPE Net | 11,433 | 12,301 | 13,335 | 13,966 | 15,258 |
| Intangibles | 169,908 | 172,708 | 175,508 | 178,308 | 181,108 |
| Other Non-Current Assets | 7,360 | 7,541 | 6,987 | 7,310 | 9,990 |
| TOTAL | $188,701 | $192,550 | $195,830 | $199,584 | $206,356 |
| Total Assets | $269,702 | $287,351 | $291,996 | $278,709 | $292,468 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,206 | 4,211 | 4,721 | 3,858 | 3,731 |
| Accrued Expenses | 10,045 | 10,535 | 8,954 | 7,871 | 7,735 |
| TOTAL | $33,704 | $33,474 | $31,884 | $34,324 | $31,289 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 10,645 | 10,238 | 9,877 | 9,097 | 9,900 |
| Other Non-Current Liabilities | 166,537 | 201,063 | 200,537 | 199,707 | 198,145 |
| TOTAL | $187,424 | $222,942 | $221,042 | $220,448 | $222,676 |
| Total Liabilities | $221,128 | $256,416 | $252,926 | $254,772 | $253,965 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,916 | 38,812 | 38,648 | 29,414 | 29,295 |
| Common Shares | 39 | 39 | 39 | 29 | 29 |
| Retained earnings | -513,084 | -500,196 | -489,738 | -473,795 | -456,862 |
| Other shareholders' equity | -532 | -574 | -731 | -648 | -725 |
| TOTAL | $48,574 | $30,935 | $39,070 | $23,937 | $38,503 |
| Total Liabilities And Equity | $269,702 | $287,351 | $291,996 | $278,709 | $292,468 |